After a period of market stagnation, Neutroplast had to react immediately in order to keep its market share and reputation. The financial crisis was not an easy obstacle to surpass. Portuguese clients were buying less (such clients who at that time represented more than 50% of total sales), banks stopped lending, suppliers imposed more strict payment schemes, and many family members still had to get paid.

Neutroplast’s administration did not have an easy problem to solve. Shall we fire? Shall we sell? Or shall we invest in our know-how? At that time, no one was sure of what surprises the financial crisis which just struck Portugal was going to bring. Many companies filed for bankruptcy, others sold for half or even a third of the price and others just fired 10%, 20%, 30%...  70% of their workforce. Fortunately Neutroplast’s team stayed tight and worked together to fight against all odds.

The final decision, surprisingly enough, was to invest. By April 2012, Neutroplast founded its new spin-off BeyonDevices which has already developed a promising applicator especially designed for women’s health, plus an innovative DPI (Dry Powder Inhaler). A couple of months later they hired 3 employees for thier Lisbon office. Moreover Neutroplast did such a great job at adjusting to market outlook that it enabled them to regain trust and credibility among existing overseas clients, as well as extended their client portfolio.
 
Now Neutroplast has raised its net exports by 30% and is hiring new production staff in addition to extending its production plant. Their team says, "We are indeed tremendously proud of our Pill Bottle Company."